Abstract
Semaphorin 3A (Sema 3A), a member of semaphorin family, serves as a guidance clue during embryonic development and is known as a candidate tumor suppressor that attenuates breast tumor progression by binding with its co-receptor, neuropilin-1 (NRP-1). However, the underlying mechanism by which Sema 3A suppresses breast tumor growth is still unexplored. In this study, we report that Sema 3A regulates phosphorylation and nuclear translocation of phosphatase and tensin homolog (PTEN) and FOXO 3a. Moreover, Sema 3A controls NRP-1-mediated PTEN-dependent FOXO 3a activation. Overexpression of PTEN and FOXO 3a enhances Sema 3A-induced attenuation of breast cancer cell migration. Chromatin immunoprecipitation and electrophoretic mobility shift assay data revealed that FOXO 3a regulates MelCAM at the transcriptional level. Furthermore, Sema 3A induces NRP-1-mediated MelCAM expression through PTEN and FOXO 3a. The data also showed that vascular endothelial growth factor-induced angiogenesis is inhibited by Sema 3A. Loss of or gain in function study revealed that Sema 3A modulates phosphorylation of PTEN and FOXO 3a and expression of MelCAM, leading to suppression of tumor growth and angiogenesis using in vivo mice model. Clinical specimen analysis revealed that reduced expression of Sema 3A and p-PTEN are correlated with enhanced breast cancer progression, further strengthening our in vitro and in vivo findings. Correlation of relapse-free survival of breast cancer patients (n=2878) with expression levels of Sema 3A, NRP-1, FOXO 3a and MelCAM were studied by Kaplan–Meier analysis. Statistical analysis revealed a close association between reduced expression of Sema 3A and MelCAM with that of poor patient’s survival. Our study demonstrated a novel mechanism of regulation of tumor suppression by Sema 3A in coordination with a chain of tumor-suppressor genes, which in turn inhibits breast cancer cell migration, tumor growth and angiogenesis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D . Global cancer statistics. CA Cancer J Clin 2011; 61: 69–90.
American Cancer Society Cancer Facts & Figures 2013, American Cancer Society: Atlanta, GA, USA, 2013.
Kolodkin AL, Matthes DJ, Goodman CS . The semaphorin genes encode a family of transmembrane and secreted growth cone guidance molecules. Cell 1993; 75: 1389–1399.
Yazdani U, Terman JR . The semaphorins. Genome Biol 2006; 7: 211.
Serini G, Maione F, Giraudo E, Bussolino F . Semaphorins and tumor angiogenesis. Angiogenesis 2009; 12: 187–193.
Staton CA, Shaw LA, Valluru M, Hoh L, Koay I, Cross SS et al. Expression of class 3 semaphorins and their receptors in human breast neoplasia. Histopathology 2011; 59: 274–282.
Yacoub M, Coulon A, Celhay O, Irani J, Cussenot O, Fromont G . Differential expression of the semaphorin 3A pathway in prostatic cancer. Histopathology 2009; 55: 392–398.
He Z, Tessier-Lavigne M . Neuropilin is a receptor for the axonal chemorepellent Semaphorin III. Cell 1997; 90: 739–751.
Glauser DA, Schlegel W . The emerging role of FOXO transcription factors in pancreatic beta cells. J Endocrinol 2007; 193: 195–207.
Fu Z, Tindall DJ . FOXOs, cancer and regulation of apoptosis. Oncogene 2008; 27: 2312–2319.
Arden KC . FoxOs in tumor suppression and stem cell maintenance. Cell 2007; 128: 235–237.
Ramaswamy S, Nakamra N, Sansal I, Bergeron L, Sellers WR . A novel mechanism of gene regulation and tumor suppression by the transcription factor FKHR. Cancer Cell 2002; 2: 81–91.
Nakamura N, Ramaswamy S, Vazquez F, Signoretti S, Loda M, Sellers WR . Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN. Mol Cell Bio 2000; 20: 8969–8982.
Dijkers PF, Birkenkamp KU, Lam EW, Thomas NS, Lammers JW, Koenderman L et al. FKHR-L1 can act as a critical effector of cell death induced by cytokine withdrawal: protein kinase-B enhanced cell survival through maintenance of mitochondrial integrity. J Cell Bio 2002; 156: 531–542.
Lehmann JM, Riethmüller G, Johnson JP . MUC18, a marker of tumor progression in human melanoma, shows sequence similarity to the neural cell adhesion molecules of the immunoglobulin superfamily. Proc Natl Acad Sci USA 1989; 86: 9891–9895.
Xie S, Luca M, Huang S, Gutman M, Reich R, Johnson JP et al. Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis. Cancer Res 1997; 57: 2295–2303.
Shih LM, Hsu MY, Palazzo JP, Herlyn M . The cell-cell adhesion receptor Mel-CAM acts as a tumor suppressor in breast carcinoma. Am J Pathol 1997; 151: 745–751.
Shih IM . The role of CD146 (Mel-CAM) in biology and pathology. J Pathol 1999; 189: 4–11.
Chakraborty G, Rangaswami H, Jain S, Kundu GC . Hypoxia regulates cross-talk between Syk and Lck leading to breast cancer progression and angiogenesis. J Biol Chem 2006; 281: 11322–11331.
Satyamoorthy K, Muyrers J, Meier F, Patel D, Herlyn M . Mel-CAM-specific genetic suppressor elements inhibit melanoma growth and invasion through loss of gap junctional communication. Oncogene 2001; 20: 4676–4684.
Li G, Kalabis J, Xu X, Meier F, Oka M, Bogenrieder T et al. Reciprocal regulation of MelCAM and AKT in human melanoma. Oncogene 2003; 22: 6891–6899.
Vazquez F, Ramaswamy S, Nakamura N, Sellers WR . Phosphorylation of the PTEN tail regulates protein stability and function. Mol Cell Bio 2000; 20: 5010–5018.
Torres J, Pulido R . The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteosome-mediated degradation. J Biol Chem 2001; 276: 993–998.
Chadborn NH, Ahmed AI, Holt MR, Prinjha R, Dunn GA, Jones GE et al. PTEN couples Sema3A signalling to growth cone collapse. J Cell Sci 2006; 119: 951–957.
Bachelder RE, Lipscomb EA, Lin X, Wendt MA, Chadborn NH, Eickholt BJ et al. Competing autocrine pathways involving alternative neuropilin-1 ligands regulate chemotaxis of carcinoma cells. Cancer Res 2003; 63: 5230–5233.
Blanco-Aparicio C, Renner O, Leal JF, Carnero A . PTEN, more than the AKT pathway. Carcinogenesis 2007; 28: 1379–1386.
Castro-Rivera E, Ran S, Brekken RA, Minna JD . Semaphorin 3B inhibits the phosphatidylinositol 3-kinase/Akt pathway though neuropilin-1 in lung and breast cancer cells. Cancer Res 2008; 68: 8295–8303.
Rena G, Woods YL, Prescott AR, Peggie M, Unterman TG, Williams MR et al. Two novel phosphorylation sites on FKHR that are critical for its nuclear exclusion. EMBO J 2002; 21: 2263–2271.
Accili D, Arden KC . FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell 2004; 117: 421–426.
Hu MC, Lee DF, Xia W, Golfman LS, Ou-Yang F, Yang JY et al. IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell 2004; 117: 225–237.
Borkhardt A, Repp R, Hass OA, Leis T, Harbott J, Kreuder J et al. Cloning and characterization of AFX, the gene that fuses to MLL in acute leukemias with a t (X; 11)(q13;q23). Oncogene 1997; 14: 195–202.
Essers MA, de Vries-Smits LM, Barker N, Polderman PE, Burgering BM, Korswagen HC . Functional interaction between beta-catenin and FOXO in oxidative stress signaling. Science 2005; 308: 1181–1184.
Tang TT, Dowbenko D, Jackson A, Toney L, Lewin DA, Dent AL et al. The forkhead transcription factor AFX activates apoptosis by induction of the BCL-6 transcriptional repressor. J Biol Chem 2002; 277: 14255–14265.
Lu Y, Lin YZ, LaPushin R, Cuevas B, Fang X, Yu SX et al. The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cells. Oncogene 1999; 18: 7034–7045.
Chakraborty G, Kumar S, Mishra R, Patil TV, Kundu GC . Semaphorin 3A suppresses tumor growth and metastasis in mice melanoma model. PLoS ONE 2012; 7: e33633 pone. 0033633.
Chakraborty G, Jain S, Kundu GC . Osteopontin promotes vascular endothelial growth factor-dependent breast tumor growth and angiogenesis via autocrine and paracrine mechanisms. Cancer Res 2008; 68: 152–161.
Miao HQ, Soker S, Feiner L, Alonso JL, Raper JA, Klagsbrun M . Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165. J Cell Biol 1999; 146: 233–242.
Gabrovska PN, Smith RA, Tiang T, Weinstein SR, Haupt LM, Griffiths LR . Semaphorin-plexin signalling genes associated with human breast tumourigenesis. Gene 2011; 489: 63–69.
Nho RS, Kahm J . beta1-Integrin-collagen interaction suppresses FoxO3a by the coordination of Akt and PP2A. J Bio Chem 2010; 285: 14195–14209.
Liu JL, Sheng X, Hortobagyi ZK, Mao Z, Gallick GE, Yung WK . Nuclear PTEN-mediated growth suppression is independent of Akt down-regulation. Mol Cell Bio 2005; 25: 6211–6224.
Emerling BM, Weinberg F, Liu JL, Mak TW, Chandel NS . PTEN regulates p300-dependent hypoxia-inducible factor 1 transcriptional activity through Forkhead transcription factor 3a (FOXO3a). Proc Natl Acad Sci USA 2008; 105: 2622–2627.
Gil A, Andres-Pons A, Fernandez E, Valiente M, Torres J, Cervera J et al. Nuclear localization of PTEN by a Ran-dependent mechanism enhances apoptosis: Involvement of an N-terimnal nuclear localization domain and multiple nuclear exclusion motifs. Mol Bio Cell 2006; 17: 4002–4013.
Trotman LC, Wang X, Alimonti A, Chen Z, Teruya-Feldstein J, Yang H et al. Ubiquitination regulates PTEN nuclear import and tumor suppression. Cell 2007; 128: 141–156.
Paik JH, Kollipara R, Chu G, Ji H, Xiao Y, Ding Z et al. FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell 2007; 128: 309–323.
Li P, Lee H, Guo S, Unterman TG, Jenster G, Bai W . AKT-independent protection of prostate cancer cells from apoptosis mediated through complex formation between the androgen receptor and FKHR. Mol Cell Biol 2003; 23: 104–118.
Seoane J, Le HV, Shen L, Anderson SA, Massague J . Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell 2004; 117: 211–223.
Bouchard C, Marquardt J, Bras A, Medema RH, Eilers M . Myc-induced proliferation and transformation require Akt-mediated phosphorylation of FoxO proteins. EMBO J 2004; 23: 2830–2840.
Potente M, Urbich C, Sasaki K, Hofmann WK, Heeschen C, Aicher A et al. Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularisation. J Clin Invest 2005; 115: 2382–2392.
Wang L, Dutta SK, Kojima T, Xu X, Khosravi-Far R, Ekker SC et al. Neuropilin-1 modulates p53/caspases axis to promote endothelial cell survival. PLoS ONE 2007; 2: e1161.
Acevedo LM, Barillas S, Weis SM, Göthert JR, Cheresh DA . Semaphorin 3A suppresses VEGF-mediated angiogenesis yet acts as a vascular permeability factor. Blood 2008; 111: 2674–2680.
Nasarre C, Roth M, Jacob L, Roth L, Koncina E, Thien A et al. Peptide-based interference of the transmembrane domain of neuropilin-1 inhibits glioma growth in vivo. Oncogene 2010; 29: 2381–2392.
Yang L, Xie S, Jamaluddin MS, Altuwaijri S, Ni J, Kim E et al. Induction of androgen receptor expression by phosphatidylinositol 3-kinase/Akt downstream substrate, FOXO3a, and their roles in apoptosis of LNCaP prostate cancer cells. J Biol Chem 2005; 280: 33558–33565.
Sinha S, Malonia SK, Mittal SP, Singh K, Kadreppa S, Kamat R et al. Coordinated regulation of p53 apoptotic targets BAX and PUMA by SMAR1 through an identical MR element. EMBO J 2010; 29: 830–842.
Rampalli S, Pavithra L, Bhatt A, Kundu TK, Chattopadhyay S . Tumor suppressor SMAR1 mediates cyclin D1 repression by recruitment of the SIN3/histone deacetylase 1 complex. Mol Cell Biol 2005; 25: 8415–8429.
Jain S, Chakraborty G, Raja R, Kale S, Kundu GC . Prostaglandin E2 regulates tumor angiogenesis in prostate cancer. Cancer Res 2008; 68: 7750–7759.
Raja R, Kale S, Thorat D, Soundararajan G, Lohite K, Mane A et al. Hypoxia-driven osteopontin contributes to breast tumor growth through modulation of HIF1α-mediated VEGF-dependent angiogenesis. Oncogene 2014; 33: 2053–2064.
Kumar V, Behera R, Lohite K, Karnik S, Kundu GC . p38 kinase is crucial for osteopontin-induced furin expression that supports cervical cancer progression. Cancer Res 2010; 70: 10381–10391.
Sharma P, Kumar S, Kundu GC . Transcriptional regulation of human osteopontin promoter by histone deacetylase inhibitor, trichostatin A in cervical cancer cells. Mol Cancer 2010; 9: 178–189.
Vacca A, Scavelli C, Serini G, Di Pietro G, Cirulli T, Merchionne F et al. Loss of inhibitory semaphorin 3A (SEMA3A) autocrine loops in bone marrow endothelial cells of patients with multiple myeloma. Blood 2006; 108: 1661–1667.
Gyorffy B, Lanczky A, Eklund AC, Denkert C, Budczies J, Li Q et al. An online survival analysis tools to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res Treat 2010; 123: 725–731.
Acknowledgements
We thank Dr B Ramanamurthy, In-charge, Experimental Animal Facility, NCCS for breeding and maintaining NOD–SCID mice. This work was supported by a grant from the Council of Scientific and Industrial Research (CSIR) (to RM and GS) and the Department of Science and Technology (DST) (to DT), Government of India. Financial support: This project was funded by the CSIR and DST, Government of India.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on the Oncogene website
Supplementary information
Rights and permissions
About this article
Cite this article
Mishra, R., Thorat, D., Soundararajan, G. et al. Semaphorin 3A upregulates FOXO 3a-dependent MelCAM expression leading to attenuation of breast tumor growth and angiogenesis. Oncogene 34, 1584–1595 (2015). https://doi.org/10.1038/onc.2014.79
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2014.79
This article is cited by
-
Expression of semaphorin 3A (SEMA3A) in breast cancer subtypes
Scientific Reports (2024)
-
Treadmill exercise with nanoselenium supplementation affects the expression of Irisin/FNDC5 and semaphorin 3A in rats exposed to cigarette smoke extract
3 Biotech (2024)
-
Tumor-associated macrophage derived IL-6 enriches cancer stem cell population and promotes breast tumor progression via Stat-3 pathway
Cancer Cell International (2022)
-
Semaphorin 4B promotes tumor progression and associates with immune infiltrates in lung adenocarcinoma
BMC Cancer (2022)
-
Marchantia polymorpha L. ethanol extract induces apoptosis in hepatocellular carcinoma cells via intrinsic- and endoplasmic reticulum stress-associated pathways
Chinese Medicine (2021)